ORGO 10-Q: SEC filing
Organogenesis Holdings
Filed with the SEC on · accession 0001193125-26-449888
ORGO filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Organogenesis Holdings filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including revenue, expenses, and segment performance.
Summary of the filing
Organogenesis Holdings filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including revenue, expenses, and segment performance. The filing also references a facility closure with related inventory and intangible asset write-downs, severance costs, and activity under an at-the-market sales agreement.
Key details
✦ Ask GOAX AI about this filing — what it means for ORGO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ORGO?
Click hereFrequently asked questions
What did ORGO file with the SEC on Nov 5, 2026?
ORGO filed a 10-Q (SEC filing). Organogenesis Holdings filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including revenue, expenses, and segment performance. The filing also references a facility closure with related inventory and intangible asset write-downs, severance costs, and activity under an at-the-market sales agreement.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other ORGO SEC filings
Get alerts when ORGO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days